CSIMarket
 
Elevance Health Inc   (NYSE: ELV)
 

Elevance Health Inc's Suppliers Performance

ELV's Supply Chain




 
ELV Costs vs Sales of Suppliers Growth Elevance Health Inc recorded an increase in cost of sales by 3.76 % year on year, sequentially cost of sales grew by 0.53 % in Q2.

More on ELV Suppliers



Elevance Health Inc recorded increase in cost of sales by 3.76 % year on year, sequentially cost of sales grew by 0.53 % in Q2.

More on ELV Suppliers




Elevance Health Inc's Comment on Supply Chain


The pharmacy services business depends on pharmacy services suppliers and third-party vendors, all of whom must comply with various federal and state laws and regulations governing pharmaceutical dispensing. These include anti-kickback laws, beneficiary inducement laws, consumer protection laws, ERISA, HIPAA, and regulations related to mail-service pharmacies. The business operates through home delivery, infusion, and specialty pharmacies and is subject to licensure, registration, and regulatory requirements from state boards of pharmacy, state-controlled substance authorities, the U.S. Drug Enforcement Agency, and the U.S. Food and Drug Administration. Noncompliance by the company or its suppliers could adversely affect the business. Additionally, new and evolving laws and regulations concerning pricing, rebates, formularies, pharmacy benefit managers, and state-specific regulations, such as recent legislation in California, may further impact operations. Government investigations into pharmacy services practices have resulted in civil penalties and corporate integrity agreements for pharmacy benefit managers, which could influence the business model.

Elevance Health Inc's Comment on Supply Chain


The pharmacy services business depends on pharmacy services suppliers and third-party vendors, all of whom must comply with various federal and state laws and regulations governing pharmaceutical dispensing. These include anti-kickback laws, beneficiary inducement laws, consumer protection laws, ERISA, HIPAA, and regulations related to mail-service pharmacies. The business operates through home delivery, infusion, and specialty pharmacies and is subject to licensure, registration, and regulatory requirements from state boards of pharmacy, state-controlled substance authorities, the U.S. Drug Enforcement Agency, and the U.S. Food and Drug Administration. Noncompliance by the company or its suppliers could adversely affect the business. Additionally, new and evolving laws and regulations concerning pricing, rebates, formularies, pharmacy benefit managers, and state-specific regulations, such as recent legislation in California, may further impact operations. Government investigations into pharmacy services practices have resulted in civil penalties and corporate integrity agreements for pharmacy benefit managers, which could influence the business model.







ELV's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Elevance Health Inc 86,846.22 201,113.00 4,956.00 97,100
Abbvie Inc 469,456.68 64,386.00 6,316.00 57,000
Fidelity National Information Services Inc 17,924.39 12,201.00 3,376.00 44,000
Fresenius Medical Care Ag 13,051.16 21,982.91 1,334.22 109,698
Gilead Sciences Inc 188,152.91 30,457.00 -3,240.00 17,000
Gsk Plc 102,328.04 32,667.00 6,289.00 254
SUBTOTAL 6,293,455.16 2,337,542.90 165,754.14 3,591,238
19 more Suppliers available

Sign in to see all suppliers for Elevance Health Inc .



Sources: Elevance Health Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Elevance Health Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.